UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy target

Annals of oncology, 2019-03, Vol.30 (3), p.486-489

2019

Volltextzugriff (PDF)

Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.985-994

2011

Volltextzugriff (PDF)

Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α₅β₁ integrin monoclonal antibody (volociximab) in cancer patients

Cancer chemotherapy and pharmacology, 2010, Vol.65 (2), p.207-217

2010

Volltextzugriff (PDF)

Translation of Anticancer Efficacy From Nonclinical Models to the Clinic

CPT: pharmacometrics and systems pharmacology, 2014-08, Vol.3 (8), p.1-4

2014

Volltextzugriff (PDF)

Why drugs fail: of mice and men revisited

Clinical cancer research, 2001-02, Vol.7 (2), p.229-230

Takimoto, C H

2001

Volltextzugriff (PDF)

Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency

Clinical cancer research, 1996-03, Vol.2 (3), p.477-481

1996

Volltextzugriff (PDF)

Identification of an RNA Binding Site for Human Thymidylate Synthase

Proceedings of the National Academy of Sciences - PNAS, 1993-01, Vol.90 (2), p.517-521

1993

Volltextzugriff (PDF)

P1276: DOSE RESPONSE PROFILE OF IGM‐2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON‐HODGKIN'S LYMPHOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1161-1162

2022

Volltextzugriff (PDF)

High Inter- and Intrapatient Variation in 5-Fluorouracil Plasma Concentrations during a Prolonged Drug Infusion

Clinical cancer research, 1999-06, Vol.5 (6), p.1347-1352

1999

Volltextzugriff (PDF)

Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro

Biochemistry (Easton), 1993-05, Vol.32 (18), p.4756-4760

1993

Volltextzugriff (PDF)

P740: IMPACT OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE ON RED BLOOD CELLS IN PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROME (HR MDS)

HemaSphere, 2022-06, Vol.6, p.635-636

2022

Volltextzugriff (PDF)

Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1492-1501

1997

Volltextzugriff (PDF)

Human plasma carboxylesterase and butyrylcholinesterase enzyme activity : correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

Cancer chemotherapy and pharmacology, 2001-04, Vol.47 (4), p.283-290

2001

Volltextzugriff (PDF)

An overview of topoisomerase I-targeting agents

Seminars in hematology, 1998-07, Vol.35 (3 Suppl 4), p.3

1998

Volltextzugriff (PDF)

Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer

Journal of clinical oncology, 1997-02, Vol.15 (2), p.735-743

1997

Volltextzugriff (PDF)

N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma

Annals of oncology, 2001-11, Vol.12 (11), p.1581-1587

2001

Volltextzugriff (PDF)

Antifolates in clinical development

Seminars in oncology, 1997-10, Vol.24 (5 Suppl 18), p.S18

Takimoto, C H

1997

Volltextzugriff (PDF)

Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells

Cancer chemotherapy and pharmacology, 1997, Vol.40 (2), p.117-125

1997

Volltextzugriff (PDF)

Enigma of Fluorouracil and Levamisole

JNCI : Journal of the National Cancer Institute, 1995-04, Vol.87 (7), p.471-473

Takimoto, C H

1995

Volltextzugriff (PDF)

A Phase I Study of Raltitrexed, an Antifolate Thymidylate Synthase Inhibitor, in Adult Patients with Advanced Solid Tumors

Clinical cancer research, 1999-09, Vol.5 (9), p.2381-2391

1999

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion

Cancer chemotherapy and pharmacology, 2001, Vol.47 (2), p.117-125

2001

Volltextzugriff (PDF)

Effects of 5-fluorouracil substitution on the RNA conformation and in vitro translation of thymidylate synthase messenger RNA

The Journal of biological chemistry, 1993-10, Vol.268 (28), p.21438-21442

1993

Volltextzugriff (PDF)

The Clinical Development of 9-Aminocamptothecin

Annals of the New York Academy of Sciences, 2000-01, Vol.922 (1), p.224-236

2000

Volltextzugriff (PDF)

Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples

Clinical cancer research, 1995-11, Vol.1 (11), p.1345-1351

1995

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients

Journal of clinical oncology, 2000-02, Vol.18 (3), p.659-667

2000

Volltextzugriff (PDF)

1 – 25 von 247

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Macrophage ‘Do not eat me’ signal, CD47, is a clinically validated cancer immunotherapy target

Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients

Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α₅β₁ integrin monoclonal antibody (volociximab) in cancer patients

Translation of Anticancer Efficacy From Nonclinical Models to the Clinic

Why drugs fail: of mice and men revisited

Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency

Identification of an RNA Binding Site for Human Thymidylate Synthase

P1276: DOSE RESPONSE PROFILE OF IGM‐2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON‐HODGKIN'S LYMPHOMA

High Inter- and Intrapatient Variation in 5-Fluorouracil Plasma Concentrations during a Prolonged Drug Infusion

Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro

P740: IMPACT OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE ON RED BLOOD CELLS IN PATIENTS WITH HIGHER‐RISK MYELODYSPLASTIC SYNDROME (HR MDS)

Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients

Human plasma carboxylesterase and butyrylcholinesterase enzyme activity : correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

An overview of topoisomerase I-targeting agents

Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer

N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma

Antifolates in clinical development

Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells

Enigma of Fluorouracil and Levamisole

A Phase I Study of Raltitrexed, an Antifolate Thymidylate Synthase Inhibitor, in Adult Patients with Advanced Solid Tumors

Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion

Effects of 5-fluorouracil substitution on the RNA conformation and in vitro translation of thymidylate synthase messenger RNA

The Clinical Development of 9-Aminocamptothecin

Effects of 9-aminocamptothecin on newly synthesized DNA in patient bone marrow samples

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients

Suchergebnisse filtern